New User:

Forgot your password?

Stock Market & Financial Investment News

News Breaks
May 2, 2014
10:24 EDTMJN, OREXOptions with increasing implied volatility: OREX MJN SWY
News For OREX;MJN From The Last 14 Days
Sign up for a free trial to see the rest of the stories you've been missing.
May 27, 2015
17:49 EDTOREXZosano Pharma elects Orexigen's Joseph Hagan to board of directors
Zosano Pharma (ZSAN) announced earlier the election of Joseph Hagan to its board of directors, effective May 22. Hagan is EVP, Chief Business & Financial Officer of Orexigen Therapeutics (OREX). Bruce Steel, chairman of Zosano, remarked that Hagan is "a seasoned business and financial executive with a significant track record in complex partnerships and transactions who will add additional breadth of perspective to our board as Zosano advances its clinical development programs in osteoporosis, hypoglycemia and migraine."
08:09 EDTMJNMead Johnson repeats FY15 adjusted EPS view $3.90-$4.00, consensus $3.99
Repeats FY15 sales growth view of about 7% constant dollar sales growth with about 5% reduction from FX. Sees FY15 gross margin approx. 64%, operating expenses approx. 39% of sales. Sees FY15 EBIT slightly above 24.5% of sales, effective tax rate "slightly better" than 24%. Sees long-term earnings growth at or above revenue growth rate. Says intends to make incremental demand-generation investments in light of anticipated gross margin improvement in 2015. Comments from slides that will be presented at the Citi Global Consumer Conference.
May 21, 2015
10:12 EDTOREXOptions with decreasing implied volatility
Subscribe for More Information

Sign up for a free trial to see the rest of the stories you've been missing.

I agree to the disclaimer & terms of use